Connection

Rodney Schlosser to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Rodney Schlosser has written about Antibodies, Monoclonal, Humanized.
Rodney Schlosser
Connection Strength
0.048
Antibodies, Monoclonal, Humanized
  1. Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count. J Allergy Clin Immunol. 2022 05; 149(5):1711-1721.e6.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.